parkinson glutathione oxidative ipsc crispr Frontiers Parkinson's disease-linked parkin mutation disrupts
Parkinson's disease linked parkin mutation disrupts recycling of synaptic vesicles in human dopaminergic neurons: Neuron Stem cells strike back: advancements in Alzheimer's and Parkinson's disease treatment and modeling efforts from 2019 to 2024 Journal of Molecular Medicine Springer Nature Link Alpha synuclein determines ferroptosis sensitivity in dopaminergic neurons via modulation of ether phospholipid membrane composition: Cell Reports Non invasive CRISPR Cas9 nanocapsules specifically edit synuclein for effective Parkinson's disease treatment ScienceDirect CRISPR Cas9 Based Technology and Its Relevance to Gene Editing in Parkinson's Disease Patient Specific iPSC Derived Astrocytes Contribute to Non Cell Autonomous Neurodegeneration in Parkinson's Disease ScienceDirect
Pay in 4 interest-free payments of $5.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





